## Clinical Context This patient has a small, well-demarcated, nodular BCC on the face without high-risk features (no perineural invasion, not on cosmetically sensitive sites, not recurrent). The diagnosis is histologically confirmed. ## Management Approach for Nodular BCC **Key Point:** Surgical excision with adequate margins (4–5 mm for nodular BCC) and complete histopathological examination is the gold standard first-line treatment for most BCCs, especially when the lesion is small to moderate in size, well-defined, and located on non-critical sites. **High-Yield:** Nodular BCC has a lower recurrence rate than infiltrative or morpheaform subtypes and is amenable to standard excision. Histology confirms complete removal. ## Why Surgical Excision Here? | Feature | Implication | |---------|-------------| | Size (1.5 cm) | Small enough for straightforward excision | | Location (cheek) | Not on eyelid, lip, or ear (high-risk sites) | | Subtype (nodular) | Lower risk of subclinical extension; responds well to excision | | Perineural invasion | Absent (no indication for Mohs) | | Histology confirmed | No need for diagnostic biopsy; proceed to definitive treatment | **Clinical Pearl:** Topical imiquimod is reserved for superficial BCC or when surgery is contraindicated. Mohs micrographic surgery is indicated for high-risk subtypes (infiltrative, morpheaform), recurrent lesions, or anatomically critical sites (eyelid, nasal ala, lip). Observation is never appropriate for confirmed BCC. **Tip:** In NEET PG, when you see a confirmed, small, nodular BCC without high-risk features, the answer is almost always standard surgical excision with margins and histopathology. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.